Our trial of ondansetron as a treatment for hallucinations in Parkinson's is restarting Date 22 November 2024
Caption Photo by Aurore Delsoir Photography Prize for work ensuring patient voice is included in research Date 31 May 2024 A partnership involving Parkinson’s UK has been recognised at the Made with Patients awards, organised by Patient Focused Medicines Development.
Parkinson's UK invests in potential new drug targeting brain inflammation Date 25 April 2024 We're providing £2.1million through our Virtual Biotech programme to develop a potential new drug which holds promise for protecting brain cells in Parkinson's.
Trial of ondansetron as a treatment for hallucinations in Parkinson's: an update Date 22 April 2024 The TOP HAT trial is closing early and we have an important update on next steps.
Awarding nearly £600,000 to support the next leaders in Parkinson's research Date 11 April 2024 Parkinson’s UK has funded two future leaders in Parkinson’s research who are pushing forward our understanding of the early stages and causes of Parkinson’s.
Gut bacteria transplant may improve Parkinson’s movement symptoms Date 8 April 2024 Early research shows transplanting gut bacteria from healthy individuals to people with Parkinson’s, called a faecal microbiota transplant, is safe and may ease motor symptoms.
Results from a phase 2 trial of lixisenatide have been published Date 4 April 2024 Lixisenatide, a diabetes drug being investigated for Parkinson’s, shows potential to slow the progression of movement symptoms.
New research study shows impact of delirium for people with Parkinson’s in hospital Date 21 March 2024 New research study shows impact of delirium for people with Parkinson’s in hospital
Skin biopsy as a potential method towards a test for Parkinson’s Date 21 March 2024 The simple skin test was able to detect a troublesome protein associated with Parkinson's and other similar conditions.
Parkinson’s UK funds nearly £450,000 for research exploring new ways to manage Parkinson’s symptoms Date 19 March 2024 Our latest round of grants fund projects which aim to improve everyday life for people living with Parkinson’s, without the need for extra medications.
Caption Image: Mint Motion for Passionate Productions An update on GDNF trials for Parkinson’s Date 28 February 2024 A further trial of a device-delivered GDNF is not going ahead, but other approaches are showing promise.
